AU2021321433A1 - Heteroaryl and heterocyclyl compounds - Google Patents

Heteroaryl and heterocyclyl compounds Download PDF

Info

Publication number
AU2021321433A1
AU2021321433A1 AU2021321433A AU2021321433A AU2021321433A1 AU 2021321433 A1 AU2021321433 A1 AU 2021321433A1 AU 2021321433 A AU2021321433 A AU 2021321433A AU 2021321433 A AU2021321433 A AU 2021321433A AU 2021321433 A1 AU2021321433 A1 AU 2021321433A1
Authority
AU
Australia
Prior art keywords
compound
alkyl
heteroalkyl
halogen
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021321433A
Other languages
English (en)
Inventor
Matthew Buchanan
Omar DE PAOLIS
Richard Heidebrecht
Christopher P. Hencken
Weiheng Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigilon Therapeutics Inc
Original Assignee
Sigilon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigilon Therapeutics Inc filed Critical Sigilon Therapeutics Inc
Publication of AU2021321433A1 publication Critical patent/AU2021321433A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2021321433A 2020-08-04 2021-08-04 Heteroaryl and heterocyclyl compounds Pending AU2021321433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063060968P 2020-08-04 2020-08-04
US63/060,968 2020-08-04
PCT/US2021/044564 WO2022031862A2 (en) 2020-08-04 2021-08-04 Heteroaryl and heterocyclyl compounds

Publications (1)

Publication Number Publication Date
AU2021321433A1 true AU2021321433A1 (en) 2023-03-02

Family

ID=80120142

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021321433A Pending AU2021321433A1 (en) 2020-08-04 2021-08-04 Heteroaryl and heterocyclyl compounds

Country Status (9)

Country Link
US (1) US20230303502A1 (cg-RX-API-DMAC10.html)
EP (1) EP4192468A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023536633A (cg-RX-API-DMAC10.html)
KR (1) KR20230048523A (cg-RX-API-DMAC10.html)
CN (1) CN116322777A (cg-RX-API-DMAC10.html)
AU (1) AU2021321433A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023002132A2 (cg-RX-API-DMAC10.html)
CA (1) CA3190778A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022031862A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4531879A1 (en) 2022-05-25 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions of secretory and/or catalytic cells and methods using the same
JP2025520113A (ja) 2022-06-03 2025-07-01 フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー 組成物及び方法
IL328729A (en) 2023-12-01 2026-07-01 Sigilon Therapeutics Inc Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2411197A (en) * 1996-04-30 1997-11-19 Affymax Technologies N.V. Methods for the synthesis of fmoc protected amines
CN103819403B (zh) * 2008-12-31 2017-01-04 阿德利克斯公司 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法
ES3036749T3 (en) * 2014-08-01 2025-09-23 Massachusetts Inst Technology Modified alginates for anti-fibrotic materials and applications
EP3215519A1 (en) * 2014-11-06 2017-09-13 Novartis AG Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
US20180185368A1 (en) * 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
CR20180229A (es) * 2015-10-29 2018-08-24 Novartis Ag Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll
KR20230156818A (ko) * 2016-10-03 2023-11-14 시질론 테라퓨틱스, 인크. 화합물, 장치, 및 이의 용도
IL315310A (en) * 2017-12-26 2024-10-01 Kymera Therapeutics Inc Irak degraders and uses thereof
CN112203646A (zh) * 2018-04-04 2021-01-08 西吉隆医疗股份有限公司 可植入颗粒和相关方法

Also Published As

Publication number Publication date
JP2023536633A (ja) 2023-08-28
WO2022031862A2 (en) 2022-02-10
BR112023002132A2 (pt) 2023-04-11
KR20230048523A (ko) 2023-04-11
US20230303502A1 (en) 2023-09-28
EP4192468A4 (en) 2024-09-11
WO2022031862A3 (en) 2022-03-24
CA3190778A1 (en) 2022-02-10
EP4192468A2 (en) 2023-06-14
CN116322777A (zh) 2023-06-23

Similar Documents

Publication Publication Date Title
EP4192468A2 (en) Heteroaryl and heterocyclyl compounds
WO2023275301A1 (en) Imidazotriazine derivatives as il-17 modulators
AU2017266325B2 (en) Imidazoles as histone demethylase inhibitors
EP3990451A1 (en) Fused imidazole derivatives as il-17 modulators
AU2013243353B2 (en) Fused cyclopentyl antagonists of CCR2
CN119866336A (zh) 毒蕈碱受体激动剂的结晶形式和盐
EP4132650A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
EP4069702A1 (en) Sstr5 antagonists
WO2023250107A1 (en) Process for preparing modulators of eukaryotic initiation factor 2b
AU2024226158A1 (en) Solid formulations and polymorphic forms of indoline inhibitors of kif18a
JP6940480B2 (ja) Fgfr阻害剤の合成方法
AU2022273544B2 (en) Methods of making a modulator of hemoglobin
KR20240148351A (ko) 브루톤 티로신 키나제 억제제의 합성
JP2025525622A (ja) Il-17モジュレーターとしてのイミダゾトリアジン誘導体
ES2977277T3 (es) Procesos para preparar (3R,4R)-1-bencil-n,4-dimetilpiperidin-3-amina o una de sus sales y procesos para preparar tofacitinib mediante el uso de la misma
KR20260052982A (ko) Pi3k 억제제의 제조 방법
WO2025008574A1 (en) 2-phenoxy-1-(4-(alkylsulfonyl)piperidin-1-yl)ethan-1-one and 3-phenyl-1-(4-(alkylsulfonyl)piperidin-1-yl)prop-2-en-1-one derivatives as gpr183 antagonists for the treatment of chronic pain
AU2022240650B2 (en) Estrogen receptor antagonist
WO2018109271A1 (en) New bromodomain inhibitors
WO2025149985A1 (en) Methods of preparing melanocortin 4 receptor agonists
ES2279093T3 (es) Procedimiento para preparar derivados imidazolicos y sus sales.
WO2017108927A1 (en) Process for preparation of ingenol 3-(3.5-diethylisoxazole-4-carboxylate)
CN118715228A (zh) 布鲁顿酪氨酸激酶抑制剂的合成
Savage et al. ASYMMETRIC SYNTHESIS OF A HOMOCHIRAL A2-ISOXAZOLINE AMINO ACID DERIVATIVE